246 related articles for article (PubMed ID: 17850748)
1. Fragile X mental retardation syndrome: structure of the KH1-KH2 domains of fragile X mental retardation protein.
Valverde R; Pozdnyakova I; Kajander T; Venkatraman J; Regan L
Structure; 2007 Sep; 15(9):1090-8. PubMed ID: 17850748
[TBL] [Abstract][Full Text] [Related]
2. New insights into Fragile X syndrome. Relating genotype to phenotype at the molecular level.
Pozdnyakova I; Regan L
FEBS J; 2005 Feb; 272(3):872-8. PubMed ID: 15670167
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of KH domains.
Valverde R; Edwards L; Regan L
FEBS J; 2008 Jun; 275(11):2712-26. PubMed ID: 18422648
[TBL] [Abstract][Full Text] [Related]
4. The C terminus of fragile X mental retardation protein interacts with the multi-domain Ran-binding protein in the microtubule-organising centre.
Menon RP; Gibson TJ; Pastore A
J Mol Biol; 2004 Oct; 343(1):43-53. PubMed ID: 15381419
[TBL] [Abstract][Full Text] [Related]
5. Tdrd3 is a novel stress granule-associated protein interacting with the Fragile-X syndrome protein FMRP.
Linder B; Plöttner O; Kroiss M; Hartmann E; Laggerbauer B; Meister G; Keidel E; Fischer U
Hum Mol Genet; 2008 Oct; 17(20):3236-46. PubMed ID: 18664458
[TBL] [Abstract][Full Text] [Related]
6. The N-terminus of the fragile X mental retardation protein contains a novel domain involved in dimerization and RNA binding.
Adinolfi S; Ramos A; Martin SR; Dal Piaz F; Pucci P; Bardoni B; Mandel JL; Pastore A
Biochemistry; 2003 Sep; 42(35):10437-44. PubMed ID: 12950170
[TBL] [Abstract][Full Text] [Related]
7. Fragile X syndrome: from molecular genetics to therapy.
D'Hulst C; Kooy RF
J Med Genet; 2009 Sep; 46(9):577-84. PubMed ID: 19724010
[TBL] [Abstract][Full Text] [Related]
8. Transport kinetics of FMRP containing the I304N mutation of severe fragile X syndrome in neurites of living rat PC12 cells.
Schrier M; Severijnen LA; Reis S; Rife M; van't Padje S; van Cappellen G; Oostra BA; Willemsen R
Exp Neurol; 2004 Oct; 189(2):343-53. PubMed ID: 15380484
[TBL] [Abstract][Full Text] [Related]
9. The fragile X mental retardation protein has nucleic acid chaperone properties.
Gabus C; Mazroui R; Tremblay S; Khandjian EW; Darlix JL
Nucleic Acids Res; 2004; 32(7):2129-37. PubMed ID: 15096575
[TBL] [Abstract][Full Text] [Related]
10. Conformational and dynamic properties of the KH1 domain of FMRP and its fragile X syndrome linked G266E variant.
Catalano F; Santorelli D; Astegno A; Favretto F; D'Abramo M; Del Giudice A; De Sciscio ML; Troilo F; Giardina G; Di Matteo A; Travaglini-Allocatelli C
Biochim Biophys Acta Proteins Proteom; 2024 Jul; 1872(4):141019. PubMed ID: 38641086
[TBL] [Abstract][Full Text] [Related]
11. Fragile X syndrome, the Fragile X related proteins, and animal models.
Hoogeveen AT; Willemsen R; Oostra BA
Microsc Res Tech; 2002 May; 57(3):148-55. PubMed ID: 12112450
[TBL] [Abstract][Full Text] [Related]
12. The nuclear microspherule protein 58 is a novel RNA-binding protein that interacts with fragile X mental retardation protein in polyribosomal mRNPs from neurons.
Davidovic L; Bechara E; Gravel M; Jaglin XH; Tremblay S; Sik A; Bardoni B; Khandjian EW
Hum Mol Genet; 2006 May; 15(9):1525-38. PubMed ID: 16571602
[TBL] [Abstract][Full Text] [Related]
13. The fragile X mental retardation protein interacts with a distinct mRNA nuclear export factor NXF2.
Lai D; Sakkas D; Huang Y
RNA; 2006 Aug; 12(8):1446-9. PubMed ID: 16790844
[TBL] [Abstract][Full Text] [Related]
14. Thermodynamics of the fragile X mental retardation protein RGG box interactions with G quartet forming RNA.
Zanotti KJ; Lackey PE; Evans GL; Mihailescu MR
Biochemistry; 2006 Jul; 45(27):8319-30. PubMed ID: 16819831
[TBL] [Abstract][Full Text] [Related]
15. Whole-brain expression analysis of FMRP in adult monkey and its relationship to cognitive deficits in fragile X syndrome.
Zangenehpour S; Cornish KM; Chaudhuri A
Brain Res; 2009 Apr; 1264():76-84. PubMed ID: 19368811
[TBL] [Abstract][Full Text] [Related]
16. Identification of messenger RNAs and microRNAs associated with fragile X mental retardation protein.
Duan R; Jin P
Methods Mol Biol; 2006; 342():267-76. PubMed ID: 16957381
[TBL] [Abstract][Full Text] [Related]
17. The fragile X syndrome: exploring its molecular basis and seeking a treatment.
Bardoni B; Davidovic L; Bensaid M; Khandjian EW
Expert Rev Mol Med; 2006 Apr; 8(8):1-16. PubMed ID: 16626504
[TBL] [Abstract][Full Text] [Related]
18. FMRP interferes with the Rac1 pathway and controls actin cytoskeleton dynamics in murine fibroblasts.
Castets M; Schaeffer C; Bechara E; Schenck A; Khandjian EW; Luche S; Moine H; Rabilloud T; Mandel JL; Bardoni B
Hum Mol Genet; 2005 Mar; 14(6):835-44. PubMed ID: 15703194
[TBL] [Abstract][Full Text] [Related]
19. RNA-Binding Specificity of the Human Fragile X Mental Retardation Protein.
Athar YM; Joseph S
J Mol Biol; 2020 Jun; 432(13):3851-3868. PubMed ID: 32343993
[TBL] [Abstract][Full Text] [Related]
20. Discrimination of common and unique RNA-binding activities among Fragile X mental retardation protein paralogs.
Darnell JC; Fraser CE; Mostovetsky O; Darnell RB
Hum Mol Genet; 2009 Sep; 18(17):3164-77. PubMed ID: 19487368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
